IndraLab

Statements

PLK2 binds KRAS and BRAF. 1 / 1

| 1

sparser

"By analyzing a public CRC dataset, it was found that a high expression of Plk2 was associated with dMMR, KRAS and BRAF mutations, and limited survival benefit for adjuvant chemotherapy in late stage CRC."

29568868

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

PLK2 binds KRAS and BRAF. 1 / 1

INDRA sources:

Databases

Reading